![Erica Whittaker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erica Whittaker
Directeur/Bestuurslid bij
Neurona Therapeutics, Inc.
Profiel
Erica Whittaker is currently a Director at Neurona Therapeutics, Inc. and a Director at StrideBio, Inc. She is also a Director at SpliceBio SL, UCB Ventures (Private Equity), Rinri Therapeutics Ltd., and Exevir Bio BV.
Previously, she worked as a Research Analyst at Merrill Lynch, Pierce, Fenner & Smith Ltd.
Actieve functies van Erica Whittaker
| Bedrijven | Functie | Begin |
|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Operate as a pre-clinical stage biotechnology company | Directeur/Bestuurslid | 22-06-2021 |
UCB Ventures London
 UCB Ventures London Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01-10-2017 |
Exevir Bio BV
 Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Directeur/Bestuurslid | - |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Directeur/Bestuurslid | 14-06-2018 |
Rinri Therapeutics Ltd.
 Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss | Directeur/Bestuurslid | 01-02-2021 |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Bestuurslid | - |
UCB Ventures (Private Equity)
 UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures invests in healthcare venture capital funds located in the US and Europe. The operating division targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Erica Whittaker
| Bedrijven | Functie | Einde |
|---|---|---|
Merrill Lynch, Pierce, Fenner & Smith Ltd.
 Merrill Lynch, Pierce, Fenner & Smith Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-01-2009 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
4
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Operate as a pre-clinical stage biotechnology company | Health Technology |
Merrill Lynch, Pierce, Fenner & Smith Ltd.
Merrill Lynch, Pierce, Fenner & Smith Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
StrideBio, Inc.
StrideBio, Inc. BiotechnologyHealth Technology Develops gene therapies | Health Technology |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
UCB Ventures (Private Equity)
UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures invests in healthcare venture capital funds located in the US and Europe. The operating division targets companies operating in the fields of health technology. It provides financing for early stage capital requirements. | Finance |
UCB Ventures London
UCB Ventures London Investment ManagersFinance Acts as an alternative investment manager | Finance |
Rinri Therapeutics Ltd.
Rinri Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops regenerative stem cell-based therapies for treatment of hearing loss | Commercial Services |
Exevir Bio BV
Exevir Bio BV Pharmaceuticals: MajorHealth Technology Develops antibody-based therapies | Health Technology |
